Company news
Halberd Corp. news in 2023
Halberd Corp.'s news releases, calls and decks from 2023, newest first.
Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com
December 12, 2023
Halberd Corporation Plans to Extend Research Partnership with Mississippi State University
November 14, 2023
Hartman, CEO, and Dr. Felder, CTO of Halberd Corp, Featured on The Street Reports Podcast
October 9, 2023
Halberd's Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)
October 3, 2023
Halberd and Athena GTX Collaborate on Advanced Traumatic Brain Injury (TBI) Monitoring and Applications for Government Contracts
September 19, 2023
Astounding Early Test Results of Halberd's Traumatic Brain Injury (TBI) Project at Mississippi State University (MSU)
September 5, 2023
Halberd’s Successful Completion of Sampling Phase Marks Major Milestone for Project at Mississippi State University (MSU)
August 21, 2023
Halberd-Mississippi State University (MSU) Testing of TBI Nasal Spray Progresses
August 13, 2023
Halberd Corporation 2Q23 CEO Letter
July 19, 2023
Halberd CEO Mid-Quarter Update
May 30, 2023
Halberd Initial Preclinical Testing Phase at Mississippi State University (MSU) Complete
May 22, 2023
Halberd Pre-Clinical Test Protocol Approved
May 8, 2023
Halberd (HALB) Pursuing a Nasal Spray to Counteract the Effects of Head Trauma
May 1, 2023
Halberd Corporation 1Q23 CEO Letter
April 24, 2023
HALB CEO, CTO and YSU's Dr. Sturrus Discuss CDC, Research Discoveries etc., on "The Street Reports Podcasts" Listen Now!
April 19, 2023
Halberd and YSU Interviewed on CBS Affiliate WKBN 5pm News as Research Advances
April 16, 2023
Halberd Begins Preclinical Testing at Mississippi State University (MSU)
April 10, 2023
Halberd's Successful Meeting with CDC Leads to Expanded Testing of Antibiotic Resistant Pathogens
April 2, 2023
Halberd and Mississippi State University (MSU) Sign Agreement to Conduct Pre-Clinical Model Tests of Nasal Spray to Block Negative Effects of Head Trauma
March 29, 2023
Halberd Eradicates All Strains of Antibiotic Resistant E. Coli Provided by the CDC at Youngstown State University
March 20, 2023
Halberd & Centers for Disease Control to Meet Regarding Eradication of Antibiotic Resistant Pathogens
March 13, 2023
Halberd Demonstrates Simultaneous Eradication of Multiple Strains of CDC Provided Antibiotic Resistant Bacteria
February 20, 2023
Halberd Corporation Announces Breakthrough in Candida auris Treatment
February 12, 2023
Halberd Demonstrates Eradication of CDC Provided Antibiotic Resistant Bacteria
February 7, 2023
Halberd to Conduct Animal Tests of Nasal Spray that Blocks Negative Effects of Head Trauma
January 30, 2023
Halberd Agrees to Animal Testing at Mississippi State University
January 23, 2023
Halberd Corporation 2022 Year End CEO Letter and 2023 Goals
January 2, 2023